Free thiomalate in plasma and urine of patients receiving sodium aurothiomalate.
AUTOR(ES)
Rudge, S R
RESUMO
Free thiomalate is measureable in the plasma and urine of patients with rheumatoid arthritis receiving sodium aurothiomalate (Myocrisin). Plasma concentrations and urinary excretion of free thiomalate were measured in 8 patients by high-performance liquid chromatography and electrochemical detection. After an initial intramuscular dose of 20 mg sodium aurothiomalate, free thiomalate was detected in plasma within 15 min, peak levels of up to 600 nmol/l occurring at 30 min. Plasma levels declined rapidly thereafter. During the first 24 h between 2 and 16% of the injected dose of aurothiomalate was recovered in the urine as free thiomalate, maximum excretion occurring during the first hour.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001224Documentos Relacionados
- Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.
- Changes in immune function in patients with rheumatoid arthritis following treatment with sodium aurothiomalate.
- Inhibition of mycoplasma-induced lymphocyte activation by sodium aurothiomalate.
- Gold levels produced by treatment with auranofin and sodium aurothiomalate.
- Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.